3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
Dexamethasone
32
Cyclophosphamide
30
fludarabine phosphate
25
Melphalan
25
Busulfan
25
Bortezomib
21
Tacrolimus
20
Lenalidomide
19
Peripheral Blood Stem Cell Transplantation
18
Mycophenolic Acid
17
Whole-Body Irradiation
16
Antilymphocyte Serum
16
fludarabine
14
Calcium Dobesilate
13
Thalidomide
12
Filgrastim
12
Granulocyte Colony-Stimulating Factor
11
Methotrexate
10
pomalidomide
9
Cyclosporine
8
Radiotherapy
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
Surveys and Questionnaires
5
Stem Cell Transplantation
5
Rituximab
5
Methylprednisolone
5
sargramostim
4
carfilzomib
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Plasma Cell
×
Doxorubicin
×
Clear all
No trials found.